<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00639964</url>
  </required_header>
  <id_info>
    <org_study_id>2007/0714</org_study_id>
    <secondary_id>2007-A00534-49</secondary_id>
    <secondary_id>PHRC 2007/R1901</secondary_id>
    <secondary_id>DGS 2007-0340</secondary_id>
    <nct_id>NCT00639964</nct_id>
  </id_info>
  <brief_title>Exploration of the Lipid Metabolism During the Diabetic Pregnancies</brief_title>
  <acronym>DIAMANT</acronym>
  <official_title>Exploration of the Lipid Metabolism During the Diabetic Pregnancies and Research for New Biological Predictors to Nutritional Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Justification:

      Intrauterine exposure to type 1 or type 2 diabetes increase the risk of macrosomia (35 % to
      50 % versus 10 % in general population) despite a good glycemic control. The consequences are
      : shoulder's dystocia, lung immaturity, caesarean section, neonatal hypoglycaemia and a high
      frequency of obesity and metabolic disorders in adults.

      The mechanisms of macrosomia are unclear; chronic hyperglycemia and subsequent
      hyperinsulinaemia observed during the diabetic pregnancy might explain only partially the
      fetal weight. Considerable interest has been generated over the last decade on the lipids and
      fatty acids alterations in diabetes pregnancies. Change in lipoproteins metabolism have been
      described associated with macrosomia. Maternal nutrition before and during pregnancy plays an
      important role in fetal growth and subsequent development of an increased susceptibility to
      obesity and diabetes in later life.

      Main objective:

      Looking for an association between maternal and fetal blood lipid parameters and birth weight
      and body fat in a context of type 1 or type 2 diabetes.

      Secondary objectives:

        -  Identify lipid markers associated with fetal macrosomia.

        -  Analyze the placenta by measuring the expression of genes implicated in the storage and
           the transfer of fatty acids.

        -  Analyze and compare the expression level of placental genes subjected to parental
           imprinting and validated in animal models.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Plan of study:

      Longitudinal study on 3 groups: 70 type 1 diabetic women, 70 type 2 diabetic women and 70
      women with normal glucose tolerance during pregnancy. Recruitment in the department of
      Diabetology and Obstetrics of CHRU of Amiens and Lille.

      Nutritional survey and sampling of blood in the 1st, 2nd and 3rd trimester of pregnancy and
      at 6 weeks post partum.

      Collection of cord blood and placental tissues. Histological and molecular analysis of
      placenta will be realized both in the departments of Anatomopathology of Lille and Amiens and
      in Biochemistry Molecular Biology of CHRU of Lille.

      Homocysteine and folate assays on cord blood will be centralized in Paris (Hospital St
      Louis).

      Main criteria of judgment

      Fetal weight corrected by the gestational age.

      Expected results:

        -  An inverse correlation between maternal and fetal blood fatty acids ratios
           (polyunsaturated fatty acids/ monounsaturated fatty acids + saturated) and birth weight
           in the diabetic groups.

        -  Differences of distribution of fatty acids of maternal and foetal erythrocytic
           phospholipids correlated with the fetal weight.

        -  Qualitative and quantitative variations of expression of placental genes such as lipases
           and genes submitted to parental imprinting.

      The biologic parameters will be confronted with the data of the nutritional survey and with
      glycemic control during pregnancy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fetal weight corrected by gestational age</measure>
    <time_frame>just after delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cholesterol (total, HDL, LDL)</measure>
    <time_frame>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>triglycerides</measure>
    <time_frame>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apolipoprotein A/B rate</measure>
    <time_frame>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>erythrocytary and plasmatic fatty acid distribution</measure>
    <time_frame>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">186</enrollment>
  <condition>Pregnancy</condition>
  <condition>Pregnancy in Diabetes</condition>
  <condition>Type 1 Diabetes Mellitus</condition>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>type 1 diabetic pregnant women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>type 2 diabetic pregnant women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy pregnant women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>healthy pregnant women with normal glucose tolerance</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood tests</intervention_name>
    <description>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</description>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
    <arm_group_label>healthy pregnant women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diet questionnaire</intervention_name>
    <description>questions about nutrition before and during pregnancy</description>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
    <arm_group_label>healthy pregnant women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>umbilical cord blood collect</intervention_name>
    <description>collected at the delivery</description>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
    <arm_group_label>healthy pregnant women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placenta collect</intervention_name>
    <description>collected at the delivery</description>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
    <arm_group_label>healthy pregnant women</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant women included before 16 amenorrhea weeks

        Exclusion Criteria:

          -  obesity (BMI &gt; 40kg/m2)

          -  subject became pregnant with medical infertility treatment

          -  tobacco &gt; 10

          -  suspected abuse of alcohol
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne VAMBERGUE, MDPHD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle FAJARDY, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univesity Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Annie MARTIN, PharmD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gilbert BRIAND, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean ROUSSEAUX, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Damien SUBTIL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe DUFOUR, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre FONTAINE, MDPHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe DERUELLE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salha FENDRI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amiens University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fran√ßoise LE GOUEFF, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Roubaix hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Delphine VINCENT-DESPLANQUE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Roubaix hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lucie BRESSON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lille University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eleonore DELARUE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Odile GAGNEUR, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU, Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2008</study_first_submitted>
  <study_first_submitted_qc>March 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2008</study_first_posted>
  <last_update_submitted>May 31, 2016</last_update_submitted>
  <last_update_submitted_qc>May 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>pregnancy</keyword>
  <keyword>macrosomia</keyword>
  <keyword>lipidics markers</keyword>
  <keyword>nutritional factors</keyword>
  <keyword>placenta</keyword>
  <keyword>umbilical blood cord</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Pregnancy in Diabetics</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

